ARCHIVES

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of April

April 25, 2014

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

NCI To Fund 23 CHOPs, More Singles Than Multiples; ACCC Expresses Concern

August 8, 1980

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981